The global cell sorting market is projected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% in the forecast period (2016-2021). Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of global Market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of market.
Geographically, the market is segmented into North America, Europe, Asia-Pacific, and RoW. Among the four geographic regions, North America is estimated to command the largest share of the market in 2016, followed by Europe and Asia-Pacific. Emerging markets, including India and China, have become attractive destinations for companies engaged in the development and marketing of cell sorters. Rising incidence and prevalence of cancer, HIV, leukemia, thalassemia, and Alzheimer’s disease is among the major driving factors for the growth of this market in China and India. For instance, according to the World Cancer Report 2014, China is witnessing an alarming rise in cancer incidences-it saw an estimated 3.07 million new cancer cases in 2012, accounting for 21.8% of the global new cancer cases. As many as 2.2 million cancer deaths (26.9% of global cancer deaths) were reported in this country in the same year. In addition to this, increasing research initiatives, expansions by key players, and technological advancements are the key factors propelling the demand for cell sorters in the emerging markets.
As of 2015, Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), and Bio-Rad Laboratories, Inc. (U.S.) dominated the global cell sorting market. In the past three years, these companies adopted product launches, product showcase, agreements, and partnerships as their key business strategies to ensure market dominance. Miltenyi Biotec GmbH (Germany), Sony Biotechnology, Inc. (U.S.), Affymetrix Inc. (U.S.), Sysmex Partec GmbH (Japan), On-Chip Biotechnologies Co., Ltd. (Japan), Cytonome/ST, LLC (U.S.), and Union Biometrica, Inc. (U.S.) are some of the other players in this market.